Tranexamic acid may promote melanocores clustering in keratinocytes through upregulation of Rab5b.
Sign Up to like & getrecommendations! Published in 2023 at "Experimental dermatology"
DOI: 10.1111/exd.14767
Abstract: Tranexamic acid (TXA) is a promising therapeutic agent in melasma that can act on multiple pathophysiologic mechanisms of melasma. However, it is unclear whether TXA affects melanin in keratinocytes. To explore the effect of TXA… read more here.
Keywords: may promote; microscopy; txa; upregulation rab5b ... See more keywords